Gut

Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications

Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide, largely due to the limited efficacy of ...
Gut

AI-empowered human microbiome research

Recent advances in high-throughput microbiome profiling have generated expansive data sets that offer unprecedented ...
gut.bmj

Differentiating gastroparesis from functional dyspepsia is no longer sufficient

We read with interest the commentary by Camilleri and Talley on whether gastroparesis and functional dyspepsia (FD) are ‘really ‘interchangeable’ diseases’. 1 Their significant efforts to improve the ...
Gut

Glycaemic control is a modifiable risk factor for pancreatic cancer development in patients with diabetes: a population-based cohort study

Background Effect of glycaemic control on pancreatic cancer (PC) development in patients with long-standing type 2 diabetes ...
gut.bmj

Setting a vision for British Society of Gastroenterology guidelines: embracing innovation while preserving methodological excellence and clinical utility

Correspondence to Dr Matthew Kurien, Division of Clinical Medicine, School of Medicine & Population Health, The University of Sheffield Faculty of Medicine Dentistry and Health, Sheffield, South ...
Gut

Gut microbiome comparability between DNA extraction kits

The recent commentary by Manning et al highlights difficulties comparing results of gastrointestinal microbiome cohort studies.1 They demonstrate how methodological heterogeneity can substantially ...
gut.bmj

Holdemanella biformis augments washed microbiota transplantation for the treatment of radiation enteritis

Background Current microbiome-based therapeutics face two prominent issues: the limited clinical efficacy of probiotics and the significant variability in the efficacy of microbiota transplantation ...
gut.bmj

British Society of Gastroenterology adult guidelines on inflammatory bowel disease: what can we learn for children and young people?

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj

Over-the-scope-clips versus standard treatment in high-risk patients with acute non-variceal upper gastrointestinal bleeding: a randomised controlled trial (STING-2)

Objective Acute non-variceal upper gastrointestinal bleeding (NVUGIB) is managed by standard endoscopic combination therapy, but a few cases remain difficult and carry a high risk of persistent or ...
gut.bmj

miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD

Objective MicroRNA (miR)-301a is known to be involved in the tumourigenesis and pathogenesis of several autoimmune diseases, but it remains unclear whether miR-301a is associated with the pathogenesis ...
gut.bmj

Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms

Correspondence to Dr Suresh T Chari, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA; chari.suresh{at}mayo.edu Objective Fukuoka ...
gut.bmj

Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis

Objectives National guidelines for the management of irritable bowel syndrome (IBS) recommend that psychological therapies should be considered, but their relative efficacy is unknown, because there ...